| Product NDC: | 0186-4020 |
| Proprietary Name: | NEXIUM |
| Non Proprietary Name: | Esomeprazole magnesium |
| Active Ingredient(s): | 20 mg/1 & nbsp; Esomeprazole magnesium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | GRANULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0186-4020 |
| Labeler Name: | AstraZeneca LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021957 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070319 |
| Package NDC: | 0186-4020-01 |
| Package Description: | 30 GRANULE, DELAYED RELEASE in 1 CARTON (0186-4020-01) |
| NDC Code | 0186-4020-01 |
| Proprietary Name | NEXIUM |
| Package Description | 30 GRANULE, DELAYED RELEASE in 1 CARTON (0186-4020-01) |
| Product NDC | 0186-4020 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Esomeprazole magnesium |
| Dosage Form Name | GRANULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20070319 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca LP |
| Substance Name | ESOMEPRAZOLE MAGNESIUM |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |